Inflammasomes are intracellular protein complexes that drive the activation of inflammatory caspases 1 . So far, four inflammasomes involving NLRP1, NLRP3, NLRC4 and AIM2 have been described that recruit the common adaptor protein ASC to activate caspase-1, leading to the secretion of mature IL-1β and IL-18 proteins 2,3 . The NLRP3 inflammasome has been implicated in the pathogenesis of several acquired inflammatory diseases 4,5 as well as cryopyrinassociated periodic fever syndromes (CAPS) caused by inherited NLRP3 mutations 6,7 . Potassium efflux is a common step that is essential for NLRP3 inflammasome activation induced by many stimuli 8,9 . Despite extensive investigation, the molecular mechanism leading to NLRP3 activation in response to potassium efflux remains unknown. Here we report the identification of NEK7, a member of the family of mammalian NIMA-related kinases (NEK proteins) 10 , as an NLRP3-binding protein that acts downstream of potassium efflux to regulate NLRP3 oligomerization and activation. In the absence of NEK7, caspase-1 activation and IL-1β release were abrogated in response to signals that activate NLRP3, but not NLRC4 or AIM2 inflammasomes. NLRP3-activating stimuli promoted the NLRP3-NEK7 interaction in a process that was dependent on potassium efflux. NLRP3 associated with the catalytic domain of NEK7, but the catalytic activity of NEK7 was shown to be dispensable for activation of the NLRP3 inflammasome. Activated macrophages formed a high-molecular-mass NLRP3-NEK7 complex, which, along with ASC oligomerization and ASC speck formation, was abrogated in the absence of NEK7. NEK7 was required for macrophages containing the CAPS-associated NLRP3(R258W) activating mutation to activate caspase-1. Mouse chimaeras reconstituted with wild-type, Nek7 −/− or Nlrp3 −/− haematopoietic cells showed that NEK7 was required for NLRP3 inflammasome activation in vivo. These studies demonstrate that NEK7 is an essential protein that acts downstream of potassium efflux to mediate NLRP3 inflammasome assembly and activation.
Notably, the NLRP3-NEK7 interaction was slightly increased by LPS priming, but was clearly enhanced after ATP stimulation (Fig. 1a-c and Extended Data Fig. 1b-d ). The interaction of NLRP3 with NEK7 was independent of ASC, caspase-1 or caspase-11 (Extended Data Fig. 1d ). To determine the regions within NLRP3 that associate with 1 Department of Pathology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA. 2 The State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China. 3 The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan 52900, Israel. | NEK7 interacts with NLRP3. a, Mass spectrometry analysis of NLRP3 and NEK7 peptides after purification of NLRP3-associated proteins. b, NLRP3-SFP was pulled down and immunoblotted with indicated antibodies. Strep, streptavidin. c, LPS-primed BMDMs were left unstimulated or stimulated with ATP for 30 min. Cell lysates were immunoprecipitated (IP) and immunoblotted (IB) with indicated antibodies. d, e, Wild-type or mutant NLRP3 (Δpyrin or ΔLRR (leucine-rich repeats)) was expressed in HEK293T cells, immunoprecipitated and analysed by immunoblotting. f, Wild-type or mutant NEK7 was co-expressed with Flag-tagged NLRP3 in HEK293T cells, immunoprecipitated and analysed by immunoblotting. Whole-cell lysates are shown as the input. aa, amino acids; HA, haemagglutinin. Results are representative of at least three independent experiments. See Supplementary Fig. 1 for gel source data.
Letter reSeArCH NEK7, we expressed Flag-tagged wild-type or mutant NLRP3 in HEK293T cells. NEK7 interacted with wild-type or mutant NLRP3 lacking the amino-terminal pyrin domain, but not with NLRP3 lacking the carboxy-terminal leucine-rich repeats ( Fig. 1d ). Furthermore, NEK7 did not associate with the singly expressed pyrin domain, the centrally located nucleotide-binding domain (NOD) or leucine-rich repeats ( Fig.  1e ), indicating that both the NOD and leucine-rich repeats are involved in the interaction with NEK7. Conversely, the catalytic domain of NEK7, but not the N-terminal 33-amino-acid extension domain, interacted with NLRP3 ( Fig. 1f ). Further analysis showed that the N-terminal region (amino acid residues 34-212), but not the C-terminal region (residues 213-302), of the NEK7 catalytic domain 11 mediates the interaction with NLRP3 ( Fig. 1f ). However, mutations of the catalytic Lys63 and Lys64 or the Gly43 amino acid residue that abolish the catalytic activity of NEK7 (refs 12, 13) did not impair the NLRP3-NEK7 interaction (Fig. 1f ). These results indicate that NEK7 interacts with NLRP3 and the interaction is enhanced in response to NLRP3-activating stimuli. We next evaluated the requirement for NEK7 in NLRP3 inflammasome activation. Because NEK7 deficiency leads to either embryonic lethality or death of pups soon after birth 14 , we generated mouse chimaeras after transplanting fetal liver cells from Nek7 +/+ or Nek7 −/− embryos into lethally irradiated recipient mice. BMDMs from mice reconstituted with Nek7 −/− cells lacked detectable expression of NEK7, but expressed normal amounts of NLRP3, caspase-1 and ASC ( Fig. 2a ). Importantly, activation of caspase-1 and IL-1β release induced by ATP, nigericin and toxin gramicidin, three stimuli that activate NLRP3, were abolished in Nek7 −/− BMDMs (Fig. 2b, c) . By contrast, activation of caspase-1 and IL-1β release in response to poly (deoxyadenylic-deoxythymidylic) acid (poly(dA:dT)) that activates the AIM2 inflammasome, or Salmonella enterica serovar Typhimurium (Salmonella) that activates the NLRC4 inflammasome, were not affected in Nek7 −/− BMDMs (Fig. 2b, c) . Likewise, caspase-1 activation and IL-1β release induced by particulate matter and the lysosome membrane damaging agent Leu-Leu-OMe (LLOMe), were impaired in Nek7 −/− BMDMs (Fig. 2d, e ). By contrast, TNF-α release induced by all tested stimuli was unaffected in Nek7 −/− BMDMs (Extended Data Fig. 2a, b ). In addition, NLRP3-dependent caspase-1 activation and IL-1β release induced by cytosolic LPS stimulation that activates the non-canonical inflammasome via caspase-11 also required NEK7 (Extended Data Fig. 2c, d) . Consistent with previous studies [15] [16] [17] , cytotoxicity induced by cytosolic LPS required caspase 11, but not NLRP3 or NEK7 (Extended Data Fig. 2e ). To ensure that impaired NLRP3 activation in Nek7 −/− BMDMs was not secondary to abnormal mouse development, we deleted Nek7 using CRISPR-Cas9 genome editing in iBMDMs. NLRP3 inflammasome activation induced by nigericin was abrogated in NEK7-deficient macrophages ( Fig. 2f , g and Extended Data Fig. 3a -c). Importantly, re-expression of NEK7 in NEK7-deficient macrophages restored NLRP3 inflammasome activation ( Fig. 2f, g) . Similarly, knockdown of NEK7 by short hairpin RNAs (shRNAs) targeting NEK7 impaired caspase-1 activation and IL-1β release, but not TNF-α production, in response to ATP, nigericin or silica (Extended Data Fig. 4a-d ). We also depleted NEK7 in BMDMs containing the activating NLRP3(R258W) mutation corresponding to the human NLRP3(R260W) mutation that causes Muckle-Wells syndrome 18 . In agreement with previous studies 19 , treatment of NLRP3(R258W) BMDMs with LPS alone was sufficient to activate caspase-1 and IL-1β release ( Fig. 2h , i). Notably, caspase-1 activation and IL-1β release elicited by LPS in NLRP3(R258W) BMDMs were impaired by NEK7 knockdown (Fig. 2h , i). These results indicate that NEK7 acts on or just downstream of both wild-type and CAPS-associated NLRP3 to regulate the inflammasome.
Stimulation of Nek7 +/+ BMDMs with the NLRP3 activators ATP and nigericin, as well as poly(dA:dT) or Salmonella, induced rapid formation of large intracellular ASC aggregates called ASC specks in the cytosol (Fig. 3a, b ). The formation of ASC specks induced by ATP or nigericin was abrogated, but unperturbed when induced by poly(dA:dT) or Salmonella, in Nek7 −/− BMDMs ( Fig. 3a, b ). Consistently, ASC oligomerization triggered by stimulation with several NLRP3 activators, but not poly (dA:dT) or Salmonella infection, was abolished in Nek7 −/− BMDMs or greatly reduced in BMDMs with knockdown of NEK7 ( Fig. 3c and Extended Data Fig. 5a -c). Activated inflammasomes assemble into high-molecular-mass multiprotein complexes 1, 20 . To assess NLRP3 inflammasome assembly, wild-type and Nek7 −/− BMDMs were stimulated with nigericin or ATP, and digitonin-solubilized cell lysates were resolved by blue native polyacrylamide gel electrophoresis (PAGE), and the blots were then immunoblotted with anti-NLRP3 and anti-NEK7 antibodies. A large oligomeric complex (>1,000 kilodaltons (kDa)) containing NLRP3 and NEK7 was induced in wild-type BMDMs after stimulation with ATP or nigericin, and this was greatly reduced or absent in stimulated Nek7 −/− and Nlrp3 −/− cells ( Fig. 3d ). To resolve the formation of NLRP3 oligomers better, we separated the samples in the first dimension by blue native PAGE and then in a second dimension by SDS-PAGE. Immunoblotting revealed that NEK7 was indeed present in a high-molecular-mass NLRP3 complex induced by ATP or nigericin in primary wild-type BMDMs, which was absent in unstimulated wild-type cells and stimulated Nek7 −/− or Nlrp3 −/− cells ( Fig. 3e ).
To determine whether the kinase activity of NEK7 is important for the regulation of the NLRP3 inflammasome, we expressed wild-type Mock represents macrophages primed with LPS without further stimulation. c, e, IL-1β release was measured. f, g, CRISPR-Cas9-generated NEK7-deficient (NEK7 knockout (KO)) iBMDMs were transduced with control or pHIV-NEK7 lentivirus, and stimulated with LPS plus nigericin. Caspase-1 activation (f) and IL-1β release (g) were analysed. h, i, Macrophages were transduced with control lentivirus or shRNA lentiviruses targeting NEK7, and stimulated with LPS. Caspase-1 activation (h) and IL-1β release (i) were analysed. IL-1β release data (c, e, g, i) are expressed as mean values. Error bars denote s.d. of triplicate wells. Results are representative of three independent experiments. See Supplementary Fig. 1 for gel source data.
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Nek7 Letter reSeArCH or mutant NEK7 with mutations at the critical catalytic lysine residues Lys63 and Lys64 or glycine residue Gly43 in Nek7 −/− iBMDMs by lentivirus-mediated transduction. All of these NEK7 mutations have been found to abolish the kinase activity of NEK7 (refs 12, 13) . Importantly, the ability of nigericin to induce caspase-1 activation and IL-1β release was not impaired in Nek7 −/− iBMDMs reconstituted with these NEK7 mutant proteins (Extended Data Fig. 6a-c) . In addition, shRNA depletion of NEK9, the kinase that phosphorylates and activates NEK7 (refs 11, 21) , or of NEK7-related kinase NEK6 did not impair the activation of the NLRP3 inflammasome (Extended Data Fig. 7a-e ). NEK7 regulates microtubule dynamics 22, 23 . However, treatment with nocodazole or colchicine, two inhibitors of tubulin polymerization, did not inhibit NLRP3 inflammasome activation and had a marginal inhibitory effect on IL-1β and TNF-α release (Extended Data Fig. 8a-e ). Furthermore, inhibition of tubulin polymerization did not affect the NLRP3-NEK7 interaction (Extended Data Fig. 8f ). Inhibition of Bruton's tyrosine kinase (BTK) that has been implicated in NLRP3 inflammasome activation 24 did not disrupt the interaction between NEK7 and NLRP3 (Extended Data Fig. 9a, b ). Additionally, we could not detect BTK in NLRP3 complexes before or after ATP stimulation (Extended Data Fig. 9b ). Stimulation of Nek7 +/+ and Nek7 −/− BMDMs with ATP, nigericin or gramicidin induced comparable levels of potassium efflux (Extended Data Fig. 10 ). Notably, the association of NLRP3 with NEK7 as well as caspase-1 activation triggered by ATP were blocked in the presence of 50 mM KCl that inhibits potassium efflux and NLRP3 activation ( Fig. 3f ). Importantly, the induced high-molecular-mass NLRP3 complex containing NEK7 was not seen in BMDMs cultured in 50 mM KCl (Fig. 3g ). These results indicate that potassium efflux promotes the NLRP3-NEK7 interaction that is required for NLRP3 inflammasome assembly and caspase-1 activation ( Fig. 3h ).
We assessed the role of NEK7 in the regulation of the inflammasome in vivo. We generated mouse chimaeras after transplanting fetal liver cells from wild-type, Nek7 −/− or Nlrp3 −/− embryos into lethally irradiated recipient mice, and IL-1β production induced by LPS challenge was assessed in the serum 25, 26 . Administration of LPS to chimaeric mice reconstituted with wild-type fetal liver cells induced IL-1β production, which was diminished similarly in chimaeric mice reconstituted with Nek7 −/− or Nlrp3 −/− haematopoietic cells (Fig. 4a ). Consistent with additional NLRP3 function in radioresistant recipient cells 27 , chimaeric Nlrp3 −/− recipients transplanted with Nek7 −/− or Nlrp3 −/− fetal liver cells showed further reductions in IL-1β production (Fig. 4a) . Notably, production of IL-6 and TNF-α in the sera of all chimaeric mice was comparable (Fig. 4b, c) . Likewise, production of IL-1β induced by intraperitoneal administration of monosodium urate (MSU) crystals, which is also largely mediated by the NLRP3 inflammasome 28 , was reduced at comparable levels in chimaeric mice reconstituted with Nek7 −/− or Nlrp3 −/− fetal liver cells (Fig. 4d) . These studies indicate that NEK7 is required for activation of the NLRP3 inflammasome in vivo.
We have shown that NEK7 is an essential factor that specifically and non-redundantly functions downstream of potassium efflux to regulate the activation of the NLRP3 inflammasome. Our results are in agreement with recent studies that identified NEK7 as a critical regulator of the NLRP3 inflammasome 29, 30 . Our studies suggest a model in which potassium efflux induced by NLRP3-activating stimuli triggers the association of NLRP3 with NEK7, leading to the assembly and activation of the NLRP3 inflammasome (Fig. 3h ). Macrophages containing the CAPS-associated NLRP3(R258W) activating mutation that 
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does not require potassium efflux for inflammasome activation 19 also required NEK7 for caspase-1 activation, suggesting that this mutant NLRP3 may be competent for NEK7 association in the absence of potassium efflux. NEK7 regulates microtubule dynamic instability and spindle assembly which required the NEK7 catalytic activity 12, 13, 22, 23 . By contrast, the catalytic activity of NEK7 is not required for NLRP3 activation. Further work is needed to understand the dual functions of NEK7. Taken together, our studies suggest that NEK7 could be a potential target of therapeutics to treat inflammatory diseases linked to NLRP3 inflammasome activation. 6 h) . After stimulation, supernatants and cell lysates were collected separately, or combined together for immunoblotting analysis. For non-canonical inflammasome activation, 1 μg of LPS-SM was packaged with 15 μl of DOTAP according to manufacturer's instructions. After 30 min incubation at room temperature, the mixtures were diluted into 1 ml Opti-MEM and added to each well of 6-well plate containing (LPS-B5)-primed macrophages (4 h priming). Four hours later, culture supernatants and cell lysates were collected for immunoblotting, and 48-well plates were used for IL-1β release and cytotoxicity assay. Gene knockdown in primary macrophages. Lentiviral pLKO.1 plasmids targeting Nek7, Nek6 and Nek9 were purchased from Sigma. Nek7 shRNA1 (TRCTRCN0000236005, targeting sequence: 5′-C CG GT GG AG TG CC GG TA G C GT TA AA CT CG AG TT TA AC GC TA CCGGCACTCCATTTTTG-3′), Nek7 shRNA2 (TRCN0000236007, 5 ′-C CG GG AG CT AC GA CA GC TA GT TA A T CT CG AG AT TA AC TA GC TGTCGTAGCTCTTTTTG-3′), Nek6 shRNA (TRCN0000274723, 5′-C CG G A GG A C AG T T CA G T GA G G TT T A CT C G AG T A AA C C TC AC TGAACTGTCCTTTTTTG-3′) and Nek9 (TRCN0000027597, 5′-CCGGCGACAACATCATTGCCTACTACTCGAGTAGTAGGCAATGATGT TGTCGTTTTT-3′) were reported in this study. pLKO.1 scramble (Addgene 1864) was used as a negative control. Lentiviruses were packaged in HEK293FT cells and concentrated by Lenti-X concentrator (Clontech). Gene knockdown in primary macrophages was performed as described previously 20 . Puromycin-selected macrophages were collected, counted and plated on day 8, and used for experiments on the next day. The knockdown efficiency was analysed by immunoblotting with antibodies against NEK7, NEK6 or NEK9. Targeting of NEK7 by CRISPR-Cas9-mediated genome editing. Lentiviral CRISPR-Cas9 targeting guide RNA (gRNA) expressing vector (lentiCRIS-PRv2) was obtained from Addgene (52961). The NEK7 knockout target sequence used was 5′-TGAAAAACCGACCAAGCCCA-3′. To generate a NEK7 knockout cell line, lentiCRISPRv2 stocks containing the target sequence 5′-TGAAAAACCGACCAAGCCCA-3′ were used to transduce iBMDMs. Three days later, single clones of puromycin-resistant cells were sorted by flow cytometry and clones with NEK7-deficiency were identified by immunoblotting with anti-NEK7 antibody. Reconstitution of NEK7 in Nek7 −/− macrophages. Immortalized Nek7 −/− macrophages were transduced with lentivirus containing pHIV-NEK7-3×HA. After 3-4 days, transduced cells were sorted by flow cytometry using eGFP as a marker. Expression of reconstituted proteins was determined by immunoblotting. Generation of chimaeras from fetal liver cells. Fetal livers were collected at day 14 of gestation from wild-type, Nek7 −/− or Nlrp3 −/− embryos. Wild-type and Nek7 −/− fetuses were genotyped with primers (wild-type, forward, 5′-AAGG CTTACTTGGTGACACACTGG-3′; reverse, 5′-CACCGTGCAGGTGACTC GAACC-3′; Nek7 −/− , forward, 5′-CCCTGGCGTTACCCAACTTAATCGCCT TGC-3′, reverse, 5′-TTCTCCGTGGGAACAAACGGCGGATTGAC-3′), which yielded a 400-base-pair (bp) wild-type DNA band and a 302-bp Nek7 mutant DNA band after electrophoresis on 1.5% agarose gel in TBE buffer. Fetal livers were collected from fetuses and processed into single-cell suspensions using a 40 μm Nylon Cell Strainer (Falcon). Approximately 5 × 10 6 fetal liver cells in 100 μl PBS were administered by retro-orbital injection into 6-week-old gender-matched wild-type or Nlrp3 −/− recipient mice that had been lethally irradiated using X-ray (Phillips RT250, Kimtron Medical) with two doses of 5.40 Gy (total 10.8 Gy). Recipient mice were allocated randomly into experimental groups. Recipient animals received antibiotics (neomycin and polymycin B) for 4 weeks after reconstitution. Eight weeks later, successful generation of chimaeras was confirmed by PCR-based analysis and animals were analysed (see above). The number of animals per group (n = 5-8) was chosen as the minimum likely required for conclusions of biological significance, established from previous experience. ASC speck staining and ASC oligomer cross-linking. BMDMs were plated on an 8-well permanox chamber slide (Thermo Scientific, 177445) overnight. Cells were primed with 200 ng ml −1 LPS for 4 h, then stimulated with ATP or nigericin, transfected with poly(dA·dT), or infected with Salmonella. After stimulation, cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and the slides were blocked with PBS buffer containing 3% BSA. Cells were stained with anti-ASC antibody and Alexa-Fluor-488-conjugated secondary antibody. DAPI was used to stain nuclei. Cell images were taken using an Olympus Fluo-View 500 confocal microscope system. For ASC oligomer cross-linking, cells were plated on 12-well plates and stimulated as indicated. Cells were lysed with PBS buffer containing 0.5% Triton X-100, and the cell lysates were centrifuged at 6,797g for 15 min at 4 °C. Supernatants were transferred to new tubes (Triton-X-soluble fractions). The Triton-X-100-insoluble pellets were washed with PBS twice and then suspended in 200 μl PBS. The pellets were then cross-linked at room temperature for 30 min by adding 2 mM bis[sulfosuccinimidy]suberate (BS 3 ). The cross-linked pellets were spun down at 6,797g for 15 min and dissolved directly in SDS sample buffer. Blue native PAGE and 2D PAGE. Blue native gel electrophoresis was performed using the Bis-Tris Native PAGE system as previously described 20, 35 . In brief, 2 × 10 6 macrophages were re-plated in 6-well plates. On the second day, cells were primed with 200 ng ml −1 LPS for 4 h, followed by stimulation with PBS (mock), 5 mM ATP (30 min) or 5 μM nigericin (1 h). Macrophages were washed once with cold PBS and then lysed in ice-cold native lysis buffer (20 mM Bis-tris, 500 mM ε-aminocaproic acid, 20 mM NaCl, 10% (w/v) glycerol, 0.5% digitonin, 0.5 mM Na 3 VO 4 , 1 mM PMSF, 0.5 mM NaF, 1× EDTA-free Roche protease inhibitor cocktail, pH 7.0) for 15 min on ice. Cell lysates were clarified by centrifugation at 20,000g for 30 min at 4 °C and analysed without further purification steps. Cell lysates were equalized after quantification of total protein using the BCA protein assay (Pierce), and then separated by 4-12% blue native PAGE. Native gels were incubated in 10% SDS solution for 5 min before transfer to PVDF membranes (Millipore), followed by conventional western blotting. In 2D PAGE, a gel slice of the natively resolved gel was placed in a dish containing 1× Laemmli sample buffer (12.5 mM Tris-Cl (pH 6.8), 5% β-mercaptoethanol 4% (w/v) SDS, 0.1% bromophenol blue, 20% (v/v) glycerol) for 10 min, microwaved on high for 20 s, and rocked for another 15 min before loading the slice into a well 4-12% SDS-PAGE gel. Because the speck was mostly lost in the pellet fraction, the analyses of the NEK7-NLRP3 interaction probably excluded proteins in the speck. Potassium efflux assay. Intracellular potassium measurements were performed as described previously 8 . In brief, macrophages were plated on 96-well plates 1 day before experiments. Culture medium was thoroughly aspirated after stimulation. Cells were lysed with 3% ultrapure HNO 3 . Intracellular potassium was then determined by inductively coupled plasma optical emission spectrometry with an Optima 2000 DV spectrometer (PerkinElmer Life Sciences) using yttrium as an internal standard. Cytokine measurements. Cytokines were measured with ELISA kits (R&D Systems). Stimulation with endotoxin in vivo. Mice were injected intraperitoneally with 20 mg kg −1 LPS (Escherichia coli 0111:B4; Sigma). The investigators were not blinded to allocation during experiments. The blood samples were collected 3 h later. Serum cytokines were measured by ELISA. The analysis was performed blindly by an independent researcher, and the experiments were not randomized. MSU-induced mouse peritonitis. Chimaeric mice were injected intraperitoneally with 1 mg MSU dissolved in 0.5 ml sterile PBS. Mice were euthanized 6 h later and peritoneal cavities were flushed with 5 ml cold PBS. Peritoneal lavage fluids were collected and cytokines were measured by ELISA after concentration using an Amicon Ultra 10K filter from Millipore. The investigators were not blinded to allocation during experiments. Serum cytokines were measured by ELISA. The analysis was performed blindly by an independent researcher, and the experiments were not randomized. Statistical analysis. No statistical methods were used to predetermine sample size. All analyses were performed using GraphPad Prism. Differences were considered significant when P < 0.05.
Extended Data Figure 1 | NEK7 interacts with NLRP3 upstream of ASC and caspase-1. a, Immortalized Nlrp3 −/− macrophages were infected with lentiviruses containing pHIV vector (Vector) or pHIV-NLRP3-SFP (NLRP3-SFP). Transduced macrophages were sorted by flow cytometry. Cells were treated as indicated. Supernatants and cell lysates were collected and analysed by immunoblotting with indicated antibodies. b, Immunoblots showing that NEK7, but not NEK6 or NEK9, interacts with NLRP3 in macrophages. NLRP3-associated proteins were pulled down from reconstituted Nlrp3 −/− macrophages by streptavidin beads, and analysed by immunoblotting with indicated antibodies. c, ATP stimulation, but not LPS priming, greatly enhances the NEK7-NLRP3 interaction. d, LPS-primed BMDMs from wild-type, Asc −/− and Casp1 −/− Casp11 −/− were left untreated or treated with 5 mM ATP for 30 min. NLRP3 protein complexes were immunoprecipitated with anti-NLRP3 antibody and analysed by immunoblotting. Data are representative of three (a, b) or two (c, d) independent experiments. See Supplementary  Figs 2 and 3 for gel source data.
Extended Data Figure 3 | NEK7 is required for activation of the NLRP3 inflammasome in macrophages. a-c, Defective NLRP3 inflammasome in NEK7-deficient macrophages. Wild-type and NEK7-deficient macrophages generated by CRISPR-Cas9 genome editing were primed with LPS, followed by stimulation with 5 μM nigericin (1 h), 5 mM ATP (30 min) or 200 ng ml −1 Alum (6 h). Cell lysates were collected and analysed for caspase-1 activation by immunoblotting (a). IL-1β (b) and TNF-α (c) release were analysed by ELISA. ELISA data (b, c) show the mean and s.d. of triplicate wells. The amounts of TNF-α release in the absence of LPS priming were below 50 pg ml −1 in the supernatants. Data are representative of three independent experiments. See Supplementary  Fig. 3 for gel source data.
Extended Data Figure 9 | Inhibition of BTK does not inhibit the NEK7-NLRP3 interaction in macrophages. a, b, Reconstituted immortalized Nlrp3 −/− macrophages were primed with LPS for 4 h. Cells were left untreated or treated with indicated concentrations of BTK inhibitor LFM-A13 for 30 min before ATP stimulation. Cell lysates were collected and analysed for caspase-1 activation by immunoblotting (a). Cell lysates were collected and subjected to pull-down with streptavidin beads, and the precipitated protein complex was analysed by immunoblotting with indicated antibodies (b). Agarose beads were used as a control. Actin is shown as a loading control. Data are representative of two independent experiments. See Supplementary Fig. 3 for gel source data.
